Naba Alsaha Medical Services Co (SAU:9546) EBIT: ﷼31.6 Mil (TTM As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SAU:9546 Naba Alsaha Medical Services Co SAU:9546
58 GF Score
Price ﷼21.38
GF Value ﷼42.04
Valuation Significantly Undervalued
! 1 Warning Sign
View Full Analysis

What is Naba Alsaha Medical Services Co EBIT?

Naba Alsaha Medical Services Co SAU:9546 58 EBIT is ﷼31.6 Mil as of Dec. 2025. GuruFocus rates SAU:9546 with a GF Score™ of 58/100 and a GF Value™ of ﷼42.04 (Significantly Undervalued). The stock has 1 warning sign investors should review.

Naba Alsaha Medical Services Co's earnings before interest and taxes (EBIT) for the six months ended in Dec. 2025 was ﷼16.6 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Dec. 2025 was ﷼31.6 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Naba Alsaha Medical Services Co's annualized ROC % for the quarter that ended in Dec. 2025 was 8.30%. Naba Alsaha Medical Services Co's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2025 was 10.38%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Naba Alsaha Medical Services Co's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2025 was 5.71%.

Naba Alsaha Medical Services Co  (SAU:9546) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Naba Alsaha Medical Services Co's annualized ROC % for the quarter that ended in Dec. 2025 is calculated as:

ROC % (Q: Dec. 2025 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Jun. 2025 ) + Invested Capital (Q: Dec. 2025 ))/ count )
=33.236 * ( 1 - 15.32% )/( (322.867 + 355.312)/ 2 )
=28.1442448/339.0895
=8.30 %

where

Invested Capital(Q: Jun. 2025 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=339.837 - 10.179 - ( 6.791 - max(0, 26.449 - 118.704+6.791))
=322.867

Invested Capital(Q: Dec. 2025 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=385.251 - 10.949 - ( 18.99 - max(0, 22.158 - 138.726+18.99))
=355.312

Note: The Operating Income data used here is two times the semi-annual (Dec. 2025) data.

2. Joel Greenblatt's definition of Return on Capital:

Naba Alsaha Medical Services Co's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2025 is calculated as:

ROC (Joel Greenblatt) %(Q: Dec. 2025 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Jun. 2025  Q: Dec. 2025
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=33.178/( ( (214.588 + max(86.987, 0)) + (238.352 + max(99.119, 0)) )/ 2 )
=33.178/( ( 301.575 + 337.471 )/ 2 )
=33.178/319.523
=10.38 %

where Working Capital is:

Working Capital(Q: Jun. 2025 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(96.136 + 9.654 + 5.538) - (10.179 + 0 + 14.162)
=86.987

Working Capital(Q: Dec. 2025 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(104.527 + 8.487 + 6.49) - (10.949 + 0 + 9.436)
=99.119

When net working capital is negative, 0 is used.

Note: The EBIT data used here is two times the semi-annual (Dec. 2025) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Naba Alsaha Medical Services Co's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Dec. 2025 )
=31.573/552.800
=5.71 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Naba Alsaha Medical Services Co EBIT Related Terms

Naba Alsaha Medical Services Co EBIT Historical Data

* Premium members only.

The historical data trend for Naba Alsaha Medical Services Co's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Naba Alsaha Medical Services Co EBIT Chart

Naba Alsaha Medical Services Co Annual Data
Trend Dec21 Dec22 Dec23 Dec24 Dec25
EBIT
27.90 29.28 55.49 25.87 31.57

Naba Alsaha Medical Services Co Semi-Annual Data
Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
EBIT Get a 7-Day Free Trial Premium Member Only 26.49 14.59 11.27 14.98 16.59

SAU:9546 vs HCA, THC, DVA: EBIT Comparison

For the Medical Care Facilities subindustry, Naba Alsaha Medical Services Co's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Naba Alsaha Medical Services Co EV-to-EBIT vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Naba Alsaha Medical Services Co's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Naba Alsaha Medical Services Co's EV-to-EBIT falls into.


SAU:9546
58GF Score
Naba Alsaha Medical Services Co SAU:9546
EBIT is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Naba Alsaha Medical Services Co EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was ﷼31.6 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBIT →
What does a EBIT of ﷼31.6 Mil mean?
Naba Alsaha Medical Services Co (SAU:9546) has a EBIT of ﷼31.6 Mil as of Dec. 2025. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Naba Alsaha Medical Services Co.
Is Naba Alsaha Medical Services Co's EBIT too high?
Naba Alsaha Medical Services Co's current EBIT is ﷼31.6 Mil. Overall, Naba Alsaha Medical Services Co has a GF Score™ of 58/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Naba Alsaha Medical Services Co's EBIT compare to HCA and THC?
Naba Alsaha Medical Services Co's EBIT of ﷼31.6 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT for a Healthcare Providers & Services company?
A good EBIT depends on the Healthcare Providers & Services industry context. However, EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT mean?
A high EBIT can signal that a stock is expensive relative to its fundamentals. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Naba Alsaha Medical Services Co. Naba Alsaha Medical Services Co's current EBIT is ﷼31.6 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Naba Alsaha Medical Services Co stock overvalued right now?
Based on GuruFocus' analysis, Naba Alsaha Medical Services Co (SAU:9546) is currently considered Significantly Undervalued. The stock's GF Value™ is ﷼42.04, compared to a current price of ﷼21.38 — trading 49.1% below its estimated fair value. The current EBIT is ﷼31.6 Mil. Naba Alsaha Medical Services Co's overall GF Score™ is 58/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT calculated?
EBIT is calculated from a company's financial statements. For Naba Alsaha Medical Services Co (SAU:9546), the current EBIT is ﷼31.6 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Naba Alsaha Medical Services Co (SAU:9546) Overvalued in 2026?

Based on GuruFocus' analysis, Naba Alsaha Medical Services Co stock appears to be undervalued. The current stock price of ﷼21.38 is trading 49.1% below its estimated GF Value™ of ﷼42.04. GuruFocus considers Naba Alsaha Medical Services Co to be Significantly Undervalued.

Key valuation signals for SAU:9546:

  • EBIT: ﷼31.6 Mil
  • GF Value™: ﷼42.04 vs. price of ﷼21.38 (49.1% below fair value)
  • GF Score™: 58/100 with 1 warning sign

No single metric tells the full story. See the SAU:9546 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Naba Alsaha Medical Services Co Business Description

Address King Faisal Street - Al Tobi, Qatif, SAU, 31911
Naba Alsaha Medical Services Co is engaged in the medical operation of private and government hospitals, health facilities, and hospital-related activities. It operates and manages Al-Zahraa Hospital, Manarat Al-Haramain Pharmacy, and the Nabaa Al-Saha branch for the practice of maintenance work and the operation of buildings. Geographically, it operates in the Kingdom of Saudi Arabia.
58GF Score

Get the complete analysis for SAU:9546

EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

﷼21.38
Price
﷼42.04
GF Value